​
​

Journey Medical (DERM) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Journey Medical Revenue Highlights

Latest Revenue (Y)

$79.18M

Latest Revenue (Q)

$14.86M

Main Segment (Y)

Qbrexza

Journey Medical Revenue by Period

Journey Medical Revenue by Year

DateRevenueChange
2023-12-31-7.48%
2022-12-31-16.69%
2021-12-31-41.78%
2020-12-31-27.52%
2019-12-31--17.52%
2018-12-31-832.37%
2017-12-31--79.89%
2016-12-31-209.38%
2015-12-31--
2014-12-31--

Journey Medical generated $79.18M in revenue during NA 2023, up 7.48% compared to the previous quarter, and up 187.02% compared to the same period a year ago.

Journey Medical Revenue by Quarter

DateRevenueChange
2024-06-30-14.01%
2024-03-31--14.60%
2023-12-31--55.83%
2023-09-30-101.14%
2023-06-30-40.60%
2023-03-31--23.51%
2022-12-31--0.93%
2022-09-30--11.89%
2022-06-30--21.48%
2022-03-31-32.99%
2021-12-31--10.67%
2021-09-30-28.27%
2021-06-30-42.63%
2021-03-31--21.89%
2020-12-31-45.26%
2020-09-30-0.34%
2020-06-30--11.85%
2020-03-31--7.39%
2019-09-30--82.69%
2019-06-30-2617.99%
2019-03-31-9.32%
2018-12-31-212.83%
2018-09-30--98.17%
2018-06-30-12970.23%
2018-03-31--77.74%
2017-12-31-25.98%
2017-09-30--
2017-06-30--
2017-03-31--95.26%
2016-12-31-18778.99%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--100.00%
2015-12-31--
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31--100.00%
2014-12-31--

Journey Medical generated $14.86M in revenue during Q2 2024, up 14.01% compared to the previous quarter, and up 121.63% compared to the same period a year ago.

Journey Medical Revenue Breakdown

Journey Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
Amzeeq---
Accutane---
Zilxi---
Ximino---
Targadox---
Qbrexza---
Exelderm---
Other Branded Products---
Qbrexa---

Journey Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Qbrexza (42.61%), Accutane (33.82%), Amzeeq (10.40%), Targadox (5.37%), Exelderm (4.02%), Zilxi (3.29%), and Ximino (0.48%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 24Mar 24Dec 23Jun 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21
Zilxi-----------
Qbrexza-----------
Amzeeq-----------
Accutane-----------
Exelderm-----------
Ximino-----------
Targadox-----------
Qbrexa-----------
Other Branded Products-----------

Journey Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Qbrexza (55.44%), Accutane (29.21%), Amzeeq (11.27%), and Zilxi (4.08%).

Journey Medical Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ORGOOrganogenesis--
ACBAurora Cannabis--
LFCRLifecore Biomedical--
ALIMAlimera Sciences--
DERMJourney Medical--
AQSTAquestive Therapeutics--
AVDLAvadel Pharmaceuticals--
JUPWSafety Shot--
EVOKEvoke Pharma--
LSDILucy Scientific Discovery--
SHPHShuttle Pharmaceuticals--

DERM Revenue FAQ

What is Journey Medical’s yearly revenue?

Journey Medical's yearly revenue for 2023 was $79.18M, representing an increase of 7.48% compared to 2022. The company's yearly revenue for 2022 was $73.67M, representing an increase of 16.69% compared to 2021. DERM's yearly revenue for 2021 was $63.13M, representing an increase of 41.78% compared to 2020.

What is Journey Medical’s quarterly revenue?

Journey Medical's quarterly revenue for Q2 2024 was $14.86M, a 14.01% increase from the previous quarter (Q1 2024), and a -13.49% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $13.03M, a -14.60% decrease from the previous quarter (Q4 2023), and a 6.69% increase year-over-year (Q1 2023). DERM's quarterly revenue for Q4 2023 was $15.26M, a -55.83% decrease from the previous quarter (Q3 2023), and a -4.44% decrease year-over-year (Q4 2022).

What is Journey Medical’s revenue growth rate?

Journey Medical's revenue growth rate for the last 3 years (2021-2023) was 25.42%, and for the last 5 years (2019-2023) was 126.74%.

What are Journey Medical’s revenue streams?

Journey Medical's revenue streams in c 23 are Amzeeq, Accutane, Zilxi, Ximino, Targadox, Qbrexza, and Exelderm. Amzeeq generated $6.2M in revenue, accounting 10.40% of the company's total revenue, down -14.37% year-over-year. Accutane generated $20.17M in revenue, accounting 33.82% of the company's total revenue, up 9.77% year-over-year. Zilxi generated $1.96M in revenue, accounting 3.29% of the company's total revenue, down -13.68% year-over-year. Ximino generated $287K in revenue, accounting 0.48% of the company's total revenue, down -94.21% year-over-year. Targadox generated $3.2M in revenue, accounting 5.37% of the company's total revenue, down -59.81% year-over-year. Qbrexza generated $25.41M in revenue, accounting 42.61% of the company's total revenue, down -4.88% year-over-year. Exelderm generated $2.4M in revenue, accounting 4.02% of the company's total revenue, down -30.84% year-over-year.

What is Journey Medical’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Journey Medical was Qbrexza. This segment made a revenue of $25.41M, representing 42.61% of the company's total revenue.